Home » Stocks » BCTG

BCTG Acquisition Corp. (BCTG)

Stock Price: $10.30 USD -0.04 (-0.39%)
Updated November 23, 4:00 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 220.19M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 16.08M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 23
Last Price $10.30
Previous Close $10.34
Change ($) -0.04
Change (%) -0.39%
Day's Open 10.60
Day's Range 10.26 - 10.73
Day's Volume 12,200
52-Week Range 9.83 - 10.88

More Stats

Market Cap 220.19M
Enterprise Value 220.19M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 16.08M
Float n/a
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 974
Short Ratio 0.13
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 8,976.91
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash -32
Net Cash / Share 0.00
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name BCTG Acquisition Corp.
Country United States
CEO Aaron I. Davis

Stock Information

Ticker Symbol BCTG
Stock Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Unique Identifier NASDAQ: BCTG
IPO Date September 3, 2020


BCTG Acquisition Corp. is a newly organized blank check company incorporated in May 2020 as a Delaware corporation formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on innovative companies in the biotechnology sector in North America and Europe in order to most effectively leverage our management team’s background and expertise.